These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 11147695

  • 1. Daclizumab (Zenapax) inhibits early interleukin-2 receptor signal transduction events.
    Goebel J, Stevens E, Forrest K, Roszman TL.
    Transpl Immunol; 2000 Nov; 8(3):153-9. PubMed ID: 11147695
    [Abstract] [Full Text] [Related]

  • 2. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
    McDyer JF, Li Z, John S, Yu X, Wu CY, Ragheb JA.
    J Immunol; 2002 Sep 01; 169(5):2736-46. PubMed ID: 12193748
    [Abstract] [Full Text] [Related]

  • 3. Effect of anti-IL-2Ralpha antibody on IL-2-induced Jak/STAT signaling.
    Tkaczuk J, Yu CL, Baksh S, Milford EL, Carpenter CB, Burakoff SJ, McKay DB.
    Am J Transplant; 2002 Jan 01; 2(1):31-40. PubMed ID: 12095053
    [Abstract] [Full Text] [Related]

  • 4. Intracellular signaling consequences of anti-IL-2Ralpha blockade by daclizumab.
    Tkaczuk J, Milford E, Yu C, Baksh S, Carpenter C, Burakoff S, McKay D.
    Transplant Proc; 2001 Jan 01; 33(1-2):212-3. PubMed ID: 11266783
    [No Abstract] [Full Text] [Related]

  • 5. Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).
    Nielsen M, Svejgaard A, Röpke C, Nordahl M, Odum N.
    Proc Natl Acad Sci U S A; 1995 Nov 21; 92(24):10995-9. PubMed ID: 7479924
    [Abstract] [Full Text] [Related]

  • 6. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
    Zhang Q, Nowak I, Vonderheid EC, Rook AH, Kadin ME, Nowell PC, Shaw LM, Wasik MA.
    Proc Natl Acad Sci U S A; 1996 Aug 20; 93(17):9148-53. PubMed ID: 8799169
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status.
    Swiatecka-Urban A.
    Paediatr Drugs; 2003 Aug 20; 5(10):699-716. PubMed ID: 14510627
    [Abstract] [Full Text] [Related]

  • 11. IL-15R alpha-chain expression during anti-CD25 treatment of cardiac allograft recipients.
    Baan CC, Balk AH, van der Plas AJ, van Gelder T, Vantrimpont PJ, Maat LP, Weimar W.
    Transplant Proc; 2002 Dec 20; 34(8):3243-5. PubMed ID: 12493434
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Curcumin blocks interleukin (IL)-2 signaling in T-lymphocytes by inhibiting IL-2 synthesis, CD25 expression, and IL-2 receptor signaling.
    Forward NA, Conrad DM, Power Coombs MR, Doucette CD, Furlong SJ, Lin TJ, Hoskin DW.
    Biochem Biophys Res Commun; 2011 Apr 22; 407(4):801-6. PubMed ID: 21443863
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy.
    Wuest SC, Edwan JH, Martin JF, Han S, Perry JS, Cartagena CM, Matsuura E, Maric D, Waldmann TA, Bielekova B.
    Nat Med; 2011 May 22; 17(5):604-9. PubMed ID: 21532597
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Association of STAT1, STAT3 and STAT5 proteins with the IL-2 receptor involves different subdomains of the IL-2 receptor beta chain.
    Delespine-Carmagnat M, Bouvier G, Bertoglio J.
    Eur J Immunol; 2000 Jan 22; 30(1):59-68. PubMed ID: 10602027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.